EMEA-002732-PIP02-20

Table of contents

Key facts

Active substance
  • Sitagliptin (hydrochloride monohydrate)
  • metformin hydrochloride
Therapeutic area
Endocrinology, -gynacology-fertility-metabolism
Decision number
P/0247/2020
PIP number
EMEA-002732-PIP02-20
Pharmaceutical form(s)
Modified-release tablet
Condition(s) / indication(s)
Treatment of type II diabetes mellitus
Route(s) of administration
Oral use
Contact for public enquiries
Adamed Pharma S.A.

E-mail: joanna.bokus@adamed.com
Tel. +48 513000208

Decision type
W: decision granting a waiver in all age groups for all conditions or indications

Decision

How useful was this page?

Add your rating